Background
The Permanent Working Group 'Cytogenetics and Society' of the European Cytogeneticists Association (ECA) prepared Cytogenetic Guidelines and Quality Assurance guidelines as a quality framework for cytogenetic laboratories in Europe in collaboration with EU sponsored Network of Excellence, 'Eurogentest' workpackage 1.4 (external quality assessment in cytogenetics). It is hoped that this document will lead to the establishment of common guidelines and standards that can be used as a reference manual in all European countries. This is particularly applicable to those countries without national guidelines, as they aim to achieve and maintain high standards. The adoption of this document by ECA will facilitate this process.
These cytogenetic guidelines are intended to assist in the development of national standards. Cytogenetic practices and regulations differ throughout Europe; hence in some instances, these guidelines may not be in accordance with national/federal laws and regulations. In such cases, those regulations already form the basis upon which the national standards operate.
These cytogenetic guidelines take into account the existing quality assessment (QA) schemes, good laboratory practice (GLP) documents, accreditation procedures and protocols from different countries, as well as international policy documents. The guidelines also include aspects of quality control and assurance for most of the routine methods currently employed by cytogenetic laboratories. The standards given within the guidelines should be considered as minimum acceptable criteria, and therefore any laboratory consistently operating below the minimum standard may be in danger of failing to maintain a quality service and satisfactory performance over an extended period of time. The guidelines should also be seen as guidance for certification and/or accreditation of cytogenetic laboratories.
Guidelines
The guidelines cover a wide range of issues, including staffing, workload recommendations reporting times, success rates, laboratory procedures, equipment, analysis, interpretation, reporting of results as well as the storage and retention of specimens and documents. Detailed guidance on the techniques and procedures for Constitutional, Oncological (Acquired) and Molecular Cytogenetics (FISH and QF-PCR) is also given. The cytogenetic guidelines include some guidance for difficult issues such as maternal cell contamination, mosaicism, pseudomosaicism, chromosomal variants and substandard analysis.
Quality assurance is an important part of the diagnostic service, and for this reason the guidelines have a separate section devoted to this specific area. Subjects that are covered include the difference between certification and accreditation, internal and external quality control and the examination process involved in accreditation. Additional information is given on the need for appropriate policies and/or documentation for laboratory management and organization, document control, quality manual, health and safety, data protection, confidentiality, training and education to enable a laboratory to become accredited.
One of the major problems for a cytogenetic laboratory is whether to accept all samples sent to the laboratory or to act as a 'gatekeeper' and accept only those samples for which there is a strong indication for cytogenetic analysis. The indications for chromosome analysis in constitutional and acquired cytogenetics given in the appendix of the guidelines will hopefully give support to those cytogenetic laboratories when they act as a 'gatekeeper'.
Finally, the guidelines reference the national and international guidelines, 1 -10 policy documents 11 -19 and other documents consulted in their preparation. As the list is not exhaustive and this is a rapidly changing area in genetics, the guidelines recommend that individuals working in this field continue to keep abreast of the current literature as well as national and international guidelines. The formation of the European external quality assessment (EQA) network is also strongly endorsed by the authors of the guidelines. While the guidelines are primarily written for diagnostic laboratories, they are equally of interest to EQA providers. As some genetic tests could be performed with a variety of technologies, EQA providers must take this into account when offering EQA schemes/programmes. Such an example could be when looking for small deletions/duplications where FISH analysis or molecular genetic techniques are more appropriate to detect the abnormality than routine chromosomal analysis. Both cytogenetic services and cytogenetic EQAprogrammes must therefore keep up to date with advancing technologies and in some cases this will involve a shift from a cytogenetic to a molecular genetic application. Consequently, in view of the rapidly changing practices and technology in cytogenetics, the guidelines will be revised regularly by the Working Group.
It is hoped that these guidelines will be used by cytogeneticists throughout Europe and may also be of interest to clinical geneticists, molecular geneticists as well as referring clinicians. The guidelines can be found in their entirety on the ECA (www.biologia.uniba.it/eca/) and EuroGentest (www.eurogentest.org) websites.
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